Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia
The objective of this guideline is to provide healthcare professionals with guidance on the management of patients with
How I treat patients with a history of heparin-induced thrombocytopenia
Blood. 2016;128(3):348-359
How I treat patients with inherited bleeding disorders who need anticoagulant therapy
Situations that ordinarily necessitate consideration of anticoagulation, such as arterial and venous thrombotic events and prevention of stroke in atrial fibrillation, become
How I treat MDS and AML in Fanconi anemia
Fanconi anemia (FA) is the most frequent genetic cause of bone marrow failure (BMF).1 More than 18 FA
How I vaccinate blood and marrow transplant recipients
Paul A. Carpenter and Janet A. Englund
Blood 2016 127:2824-2832
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J. Borowitz, Michelle M. Le Beau, Clara D. Bloomfield, Mario Cazzola and James W. Vardiman
Blood 2016 127:2391-2405
Stem Cell Transplantation for Children with Malignant Diseases – למתמחים
מצגת מאת Jerry Stein
How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver
George B. McDonald
Blood 2016 127:1544-1550
How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation
Alpana Waghmare, Janet A. Englund, Michael Boeckh
Blood Jun 2016, 127 (22) 2682-2692; DOI: 10.1182/blood-2016-01-634873
